within Pharmacolibrary.Drugs.ATC.J;

model J01FA06
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.00019,
    adminDuration  = 600,
    adminMass      = 150 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0312,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.010833333333333334,
    Tlag           = 19.8,            
    Vdp             = 0.041100000000000005,
    k12             = 11.3,
    k21             = 11.3
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01FA06</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Roxithromycin is a semi-synthetic macrolide antibiotic derived from erythromycin. It is used for the treatment of respiratory tract, urinary, and soft tissue infections caused by susceptible organisms. It is approved for use in multiple countries, but its use may be limited or not approved in the United States.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers following a single oral dose of roxithromycin.</p><h4>References</h4><ol><li><p>Britzi, M, et al., &amp; Lubart, E (2015). Roxithromycin Pharmacokinetics in Hospitalized Geriatric Patients: Oral Administration of Whole Versus Crushed Tablets. <i>Therapeutic drug monitoring</i> 37(4) 512–515. DOI:<a href=\"https://doi.org/10.1097/FTD.0000000000000203\">10.1097/FTD.0000000000000203</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26186658/\">https://pubmed.ncbi.nlm.nih.gov/26186658</a></p></li><li><p>Li, C, et al., &amp; Choi, JS (2008). Effects of roxithromycin on the pharmacokinetics of loratadine after oral and intravenous administration of loratadine in rats. <i>European journal of drug metabolism and pharmacokinetics</i> 33(4) 231–236. DOI:<a href=\"https://doi.org/10.1007/BF03190877\">10.1007/BF03190877</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/19230596/\">https://pubmed.ncbi.nlm.nih.gov/19230596</a></p></li><li><p>Lassman, HB, et al., &amp; Mezzino, MJ (1988). Pharmacokinetics of roxithromycin (RU 965). <i>Journal of clinical pharmacology</i> 28(2) 141–152. DOI:<a href=\"https://doi.org/10.1002/j.1552-4604.1988.tb05738.x\">10.1002/j.1552-4604.1988.tb05738.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3360966/\">https://pubmed.ncbi.nlm.nih.gov/3360966</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01FA06;
